The U.S. Food and Drug Administration (FDA) has given positive feedback to Annovis Bio’s plans to start two Phase 3 clinical trials of buntanetap (ANVS401) as an oral therapy for early- and late-stage Parkinson’s disease. The feedback followed a review of data from a Phase 2 clinical trial showing significant gains in motor skills among early Parkinson’s patients treated once […]

A phase 1/2a clinical trial of the first allogeneic RNA cell therapy in multiple myeloma has begun after dosing its first patient this week. The trial aims to examine the treatment — Descartes-25 — in 20 patients with relapsed/refractory multiple myeloma. “Patients with relapsed and/or refractory multiple myeloma have few treatment options remaining,” said Dr. […]

Biotricity said Monday that it received FDA 510(k) clearance for its Biotres cardiac monitoring device, a three-lead holter for continuous electrocardiogram and arrhythmia monitoring in lower risk patients. Biotres will be widely available for sale from April 1. CEO Waqaas Al-Siddiq remarked that the device “is designed for comfort for long-term wear.” He added that “cardiac […]